2023
Hybridan LLP – Licencing of Midkine IP to Randox
20 February 2023
2022
Hybridan LLP – Completion of Oncogeni Acquisition
16 September 2022
Hybridan LLP - Initiation of Coverage
12 September 2022
Optiva Securities - Research Report
17 May 2022
Pitt Street - Evaluation Report
10 January 2022